Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Index Level signals can help align your purchase or sale timing with market momentum, giving you a clearer framework for decisions and risk control.
25,526 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
A new ETF aims to monetize the price swings of Rocket Lab and other space names by selling weekly put spreads to fund...
Markets brace for a year where prices rise while growth falters. This report explains why stagflation: word year 2026...
UBS boosts its price target on Xcel Energy to $89 while maintaining a Buy rating, saying the stock could year-end hig...
AST SpaceMobile has captured attention with a surge tied to high-profile deals. This guide breaks down what the stock...
A tiny pre-IPO tech winner is closing its round for retail investors as millions log hours in VR workspaces. Here’s w...
A single wall street analyst thinks Tilray could deliver a sizable rally in the coming weeks. This article breaks dow...
After a challenging stretch, small-cap stocks may be poised for a revival in 2026. This guide breaks down the signals...
Inflation is rising, yet improved mortgage spreads are keeping 30-year fixed rates below 7%. Borrowers should watch h...
A pivotal moment in monetary policy unfolds as Warsh is confirmed to lead the Fed, with investors weighing how his st...
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Bitcoin faces a tough test as ETF outflows converge with rising yields and a global risk-on mood. The phrase bitcoin ...